ZIOP - Ziopharm Oncology Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ZIOP (1107421)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
7 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-01-02
ZIOPMauney David M MdPresS - Sale$4.55-22,394195,278-10%-$101,893
D
2020-01-02
ZIOPLafond Kevin GSVP, Treasurer, CAOS - Sale+OE$4.55-21,57063,985-25%-$98,144
2020-01-02
ZIOPHadfield RobertGC, SecretaryS - Sale$4.55-16,853100,719-14%-$76,681
2020-01-02
ZIOPDe Groot EleanorEVP, GM Cell TherapyS - Sale$4.55-24,890174,333-12%-$113,250
2020-01-02
ZIOPBuck JillEVP, GM Gene TherapyS - Sale$4.55-27,923173,710-14%-$127,050
D
2019-12-30
ZIOPCooper Laurence James NeilCEOS - Sale+OE$4.88-110,6941,733,273-6%-$540,187
D
2019-11-26
ZIOPLafond Kevin GSVP, Treasurer, CAOS - Sale+OE$5.25-11,66785,555-12%-$61,252
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top